Hackensack University Medical Center Interventional Cardiologists Are Leaders in Multicenter Clinical Trial of Percutaneous Heart Pump Added to Cardiac Catheterization
Newswise — HACKENSACK , N.J. — Hackensack University Medical Center interventional cardiologists are regional leaders in the multicenter national P...
Newswise — HACKENSACK , N.J. — Hackensack University Medical Center interventional cardiologists are regional leaders in the multicenter national PROTECT IV clinical trial, which is evaluating the effectiveness of a novel treatment for high-risk patients with complex heart disease and reduced heart function who require cardiac catheterization. Doctors here treated the first patient in New Jersey enrolled in this study, and Haroon Faraz, M.D., director of Interventional Cardiology Research, Hackensack University Medical Center and Principal Investigator for the PROTECT IV study, was recently appointed Regional Lead for the PROTECT IV Trial for the Southeast.